Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Genagon Therapeutics AB

Closing information (x1000 SEK)

Closing information 2022/12 2021/12 2020/12
Turnover 74 Less Arrow 35 Less Arrow 0
Financial expenses 0 Equal arrow 0 More Arrow 1
Earnings before taxes -9,827 More Arrow -8,743 More Arrow -5,218
EBITDA -9,821 More Arrow -8,739 More Arrow -5,211
Total assets 5,681 More Arrow 11,638 Less Arrow 2,476
Current assets 5,658 More Arrow 11,609 Less Arrow 2,476
Current liabilities 683 More Arrow 1,004 Less Arrow 647
Equity capital 4,998 More Arrow 10,634 Less Arrow -2,561
- share capital 204 Less Arrow 188 Less Arrow 124
Employees (average) 3 Equal arrow 3 More Arrow 4

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 88.0% More Arrow 91.4% Less Arrow -103.4%
Turnover per employee 25 Less Arrow 12 Less Arrow 0
Profit as a percentage of turnover -13279.7% Less Arrow -24980.0%
Return on assets (ROA) -173.0% More Arrow -75.1% Less Arrow -210.7%
Current ratio 828.4% More Arrow 1156.3% Less Arrow 382.7%
Return on equity (ROE) -196.6% More Arrow -82.2% More Arrow 203.7%
Change turnover 39 Less Arrow 35 Less Arrow 0
Change turnover % 111%
Chg. No. of employees 0 Less Arrow -1 Equal arrow -1
Chg. No. of employees % 0% Less Arrow -25% More Arrow -20%

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.